Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02590458 · ClinicalTrials.gov registry record · Early Phase 1
Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer
A Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 131
- Enrollment target
NCT02590458: Completed Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT02590458 is a Early Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 131 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (147% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02590458, a Early Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 131 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to test if a short breast MRI scan (about 10 minutes) can be used for breast cancer screening in high risk people and to learn if it is as effective as a routine breast MRI scan (30-60 minutes).
Primary Outcome
Radiologists blinded to patient outcome review images from each study independently and rate the possibility of breast cancer using BI-RADS score. BIRADS 0, 3,4, 5 considered positive, BIRADS 1 and 2 considered negative results for the analysis. Each reader's score for a given case assessed both independently and on a separate session, as consensus.
Interventions
- BEHAVIORAL Questionnaire
- PROCEDURE Short Breast MRI (SBMRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2015-10-26 |
| Est. Completion | 2020-11-24 |
| Phase | Early Phase 1 |
What the finished NCT02590458 record still lists
NCT02590458 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (147% higher).
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT02590458 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02590458 about?
NCT02590458 is a clinical study titled "Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer". The goal of this clinical research study is to test if a short breast MRI scan (about 10 minutes) can be used for breast cancer screening in high risk people and to learn if it is as effective as a routine breast MRI scan (30-60 minutes).
What is the current status of trial NCT02590458?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 131 participants. The study started on 2015-10-26. Estimated completion is 2020-11-24.
What interventions are being tested in trial NCT02590458?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Short Breast MRI (SBMRI) (PROCEDURE).
Who is sponsoring clinical trial NCT02590458?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02590458's enrollment target sits among peer trials
131 133rd of 2000 higher than 1,867 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI